ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.968,83
1,73%
Dow Jones
43.119,55
1,84%
Euro vs US Dollar
1,04419
0,75%
Bitcoin
96.981,84
-0,48%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Lifecore Biomedical Inc (LFCR)

  7. Lifecore Biomedical Inc (LFCR) News

LFCR

Lifecore Biomedical (LFCR)

Lifecore Biomedical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LFCR
DatumZeitQuelleÜberschriftSymbolFirma
19/12/202422h05GlobeNewswire Inc.Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025NASDAQ:LFCRLifecore Biomedical Inc
19/12/202413h00GlobeNewswire Inc.Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder TreatmentNASDAQ:LFCRLifecore Biomedical Inc
10/12/202422h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LFCRLifecore Biomedical Inc
10/12/202422h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LFCRLifecore Biomedical Inc
26/11/202423h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
26/11/202422h05GlobeNewswire Inc.Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMONASDAQ:LFCRLifecore Biomedical Inc
21/11/202422h17GlobeNewswire Inc.Lifecore Biomedical Hosts Virtual Investor DayNASDAQ:LFCRLifecore Biomedical Inc
21/11/202413h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
20/11/202416h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
12/11/202422h05GlobeNewswire Inc.Lifecore Biomedical to Present at Stephens Annual Investment ConferenceNASDAQ:LFCRLifecore Biomedical Inc
12/11/202420h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
08/11/202422h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
07/11/202413h00GlobeNewswire Inc.Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024NASDAQ:LFCRLifecore Biomedical Inc
04/11/202413h00GlobeNewswire Inc.Lifecore Biomedical Appoints Thomas Guldager as Vice President, OperationsNASDAQ:LFCRLifecore Biomedical Inc
31/10/202421h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
29/10/202421h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LFCRLifecore Biomedical Inc
23/10/202422h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LFCRLifecore Biomedical Inc
23/10/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LFCRLifecore Biomedical Inc
16/10/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LFCRLifecore Biomedical Inc
10/10/202422h40Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LFCRLifecore Biomedical Inc
10/10/202422h38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LFCRLifecore Biomedical Inc
10/10/202422h37Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:LFCRLifecore Biomedical Inc
10/10/202422h36Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:LFCRLifecore Biomedical Inc
07/10/202419h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
04/10/202413h41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LFCRLifecore Biomedical Inc
04/10/202413h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
04/10/202413h30GlobeNewswire Inc.Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate UpdateNASDAQ:LFCRLifecore Biomedical Inc
04/10/202413h20GlobeNewswire Inc.Lifecore Biomedical Raises $24.3 Million in Private Placement of Common StockNASDAQ:LFCRLifecore Biomedical Inc
03/10/202422h05GlobeNewswire Inc.Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024NASDAQ:LFCRLifecore Biomedical Inc
01/10/202413h00GlobeNewswire Inc.Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation TechnologyNASDAQ:LFCRLifecore Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:LFCR

Kürzlich von Ihnen besucht

CCOM
US30
US 30
NYSE
DIS
Walt Disney
TG
ALV
Allianz
NYSE
NKE
Nike
PM
XAUUSD
Gold vs US Dollar
DBI
TDXP
Tec DAX
NYSE
JPM
JP Morgan Chase
NASDAQ
TSLA
Tesla
TG
MBG
MercedesBenz
FX
EURJPY
Euro vs Yen
TG
D7G
Nel ASA
TG
LHA
Deutsche Lufthansa
COIN
ADAUSD
Cardano
FX
EURUSD
Euro vs US Dollar
TG
NOV
Novo Nordisk
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten